Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.

[1]  J. Alberú,et al.  Probability of deceased donor kidney transplantation based on % PRA. , 2013, Transplant immunology.

[2]  A. Courtney,et al.  Effects of HLA-Matched Blood Transfusion for Patients Awaiting Renal Transplantation , 2012, Transplantation.

[3]  Chiu-Ching Huang,et al.  Survival Analysis: Comparing Peritoneal Dialysis and Hemodialysis in Taiwan , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  P. Aljama,et al.  Microinflammation and endothelial damage in hemodialysis. , 2008, Contributions to nephrology.

[5]  C. Tetta,et al.  Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. , 2007, Kidney international.

[6]  M. Franco,et al.  Post‐Transplant Anti‐HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  B. Einollahi,et al.  Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients. , 2005, Transplantation proceedings.

[8]  J. Gloor.  Kidney transplantation in the hyperimmunized patient. , 2005, Contributions to nephrology.

[9]  M. Haberal,et al.  Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes. , 2004, Transplant immunology.

[10]  J. T. Fitzgerald,et al.  PRETRANSPLANT RECIPIENT CYTOMEGALOVIRUS SEROPOSITIVITY AND HEMODIALYSIS ARE ASSOCIATED WITH DECREASED RENAL ALLOGRAFT AND PATIENT SURVIVAL , 2004, Transplantation.

[11]  L. Thacker,et al.  HLA phenotypes of ESRD patients are risk factors in the panel‐reactive antibody (PRA) response , 2001, Clinical transplantation.

[12]  J. Worthington,et al.  A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. , 2001, Human immunology.

[13]  C. Messaed,et al.  Panel-reactive antibodies using complement-dependent cytotoxicity, flow cytometry, and ELISA in patients awaiting renal transplantation or transplanted patients: a comparative study. , 2001, Transplantation proceedings.

[14]  B. Kiberd,et al.  Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants , 2000, Clinical transplantation.

[15]  D. Dunn,et al.  SHOULD I ACCEPT THIS KIDNEY , 1999 .

[16]  G Opelz,et al.  HLA compatibility and organ transplant survival. Collaborative Transplant Study. , 1999, Reviews in immunogenetics.

[17]  G. Russell,et al.  Dialysis modality and delayed graft function after cadaveric renal transplantation. , 1999, Journal of the American Society of Nephrology : JASN.

[18]  N. Atkins,et al.  Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  S. Sezer,et al.  Comparison of panel reactive antibody levels with clinical and laboratory parameters in end-stage renal disease patients. , 1998, Transplantation proceedings.

[20]  B. Susskind,et al.  Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. , 1996, Transplantation.

[21]  G. Land,et al.  COMPARISON OF PANEL‐REACTIVE ANTIBODY LEVELS IN CAUCASIAN AND AFRICAN AMERICAN RENAL TRANSPLANT CANDIDATES , 1995, Transplantation.

[22]  A. Fabrega,et al.  Presensitization and frequency of positive crossmatches in black and nonblack renal transplant candidates. , 1993, Transplantation proceedings.

[23]  A. Valla.  Déleucocytation des produits sanguins et immunisation anti-HLA , 1993 .

[24]  Å. Valla.  [Leukocyte depletion of blood products and anti-HLA immunization]. , 1993, Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine.

[25]  P. Kimball,et al.  INFLUENCE OF RACE ON CROSSMATCH OUTCOME AND RECIPIENT ELIGIBILITY FOR TRANSPLANTATION1 , 1991 .

[26]  E. Everett,et al.  Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects. , 1987, Transplantation.

[27]  M. Olmer,et al.  Anti-HLA immunisation in 130 haemodialysed patients. , 1979, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.